{"id":"https://openalex.org/W4362477313","doi":"https://doi.org/10.1158/1535-7163.22498744","title":"Supplementary Figure 2 from Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity","display_name":"Supplementary Figure 2 from Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362477313","doi":"https://doi.org/10.1158/1535-7163.22498744"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22498744","doi":"https://doi.org/10.1158/1535-7163.22498744","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22498744","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22498744","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100780036","display_name":"Yu Cao","orcid":"https://orcid.org/0000-0002-9682-0980","observed_orcids":["https://orcid.org/0000-0002-9682-0980"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Cao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038349275","display_name":"James D. Marks","orcid":"https://orcid.org/0000-0003-0562-3517","observed_orcids":["https://orcid.org/0000-0003-0562-3517"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James D. Marks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101856574","display_name":"Qian Huang","orcid":"https://orcid.org/0000-0002-3778-2419","observed_orcids":["https://orcid.org/0000-0002-3778-2419"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061278758","display_name":"Stephen I. Rudnick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen I. Rudnick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068012778","display_name":"Chiyi Xiong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chiyi Xiong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073876235","display_name":"Walter N. Hittelman","orcid":"https://orcid.org/0000-0002-0048-6640","observed_orcids":["https://orcid.org/0000-0002-0048-6640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Walter N. Hittelman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100580537","display_name":"Xiaoxia Wen","orcid":"https://orcid.org/0000-0002-7749-0744","observed_orcids":["https://orcid.org/0000-0002-7749-0744"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoxia Wen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083046767","display_name":"John W. Marks","orcid":"https://orcid.org/0009-0000-0035-2872","observed_orcids":["https://orcid.org/0009-0000-0035-2872"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John W. Marks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102752340","display_name":"Lawrence H. Cheung","orcid":"https://orcid.org/0000-0002-6715-6574","observed_orcids":["https://orcid.org/0000-0002-6715-6574"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lawrence H. Cheung","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003675387","display_name":"Kim Boland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kim Boland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100373897","display_name":"Chun Li","orcid":"https://orcid.org/0000-0002-2376-4703","observed_orcids":["https://orcid.org/0000-0002-2376-4703"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chun Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050269562","display_name":"Gregory Paul Adams","orcid":"https://orcid.org/0000-0003-4207-2881","observed_orcids":["https://orcid.org/0000-0003-4207-2881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gregory P. Adams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048281793","display_name":"Michael G. Rosenblum","orcid":"https://orcid.org/0000-0002-3044-6121","observed_orcids":["https://orcid.org/0000-0002-3044-6121"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael G. Rosenblum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.040699999779462814,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-chain-antibody","display_name":"single-chain antibody","score":0.9010000228881836},{"id":"https://openalex.org/keywords/immunotoxins","display_name":"immunotoxins","score":0.8489999771118164},{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.9049999713897705},{"id":"https://openalex.org/keywords/receptor-extracellular-domain","display_name":"receptor extracellular domain","score":0.7879999876022339},{"id":"https://openalex.org/keywords/antibody-affinity","display_name":"antibody affinity","score":0.640999972820282},{"id":"https://openalex.org/keywords/off-target-toxicity","display_name":"off-target toxicity","score":0.8849999904632568},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/design-optimization","display_name":"design optimization","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C115085202","wikidata":"https://www.wikidata.org/wiki/Q425665","display_name":"Immunotoxin","level":4,"score":0.9171364307403564},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.6680502891540527},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5448482036590576},{"id":"https://openalex.org/C2776872082","wikidata":"https://www.wikidata.org/wiki/Q181874","display_name":"HER2/neu","level":4,"score":0.46247899532318115},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4379570782184601},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35700297355651855},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18101677298545837},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17235639691352844},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12457793951034546},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.10361793637275696},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07330504059791565},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.055905550718307495},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22498744","doi":"https://doi.org/10.1158/1535-7163.22498744","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22498744","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22498744.v1","doi":"https://doi.org/10.1158/1535-7163.22498744.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22498744.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Single-Chain_Antibody-Based_Immunotoxins_Targeting_Her2_neu_Design_Optimization_and_Impact_of_Affinity_on_Antitumor_Efficacy_and_Off-Target_Toxicity/22498744/1/files/39957127.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22498744","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Single-Chain_Antibody-Based_Immunotoxins_Targeting_Her2_neu_Design_Optimization_and_Impact_of_Affinity_on_Antitumor_Efficacy_and_Off-Target_Toxicity/22498744","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22498744","doi":"https://doi.org/10.1158/1535-7163.22498744","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22498744","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W4362477313.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2324623325","https://openalex.org/W4362478068","https://openalex.org/W2117884978","https://openalex.org/W4361825112","https://openalex.org/W2117203118","https://openalex.org/W2007336991","https://openalex.org/W1980023938","https://openalex.org/W2070942888","https://openalex.org/W4321478666","https://openalex.org/W2122411218"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"1631KB,":[3],"Competitive":[4],"cytotoxicity":[5],"of":[6,12],"the":[7,10],"scFv/rGel":[8],"in":[9],"presence":[11],"free":[13],"Her2/neu":[14],"ECD.":[15]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}